Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Maria Beatrice Alora-Palli, M.D.

Concepts (90)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Coal Tar22010180.880 Why?
Dermatologic Agents420153020.760 Why?
Calcitriol220103150.750 Why?
Psoriasis320118900.550 Why?
Photosensitivity Disorders22020870.240 Why?
Tretinoin220155140.210 Why?
Administration, Cutaneous320126860.210 Why?
Skin Aging220171450.190 Why?
Single-Blind Method3201516080.190 Why?
Iontophoresis12015750.150 Why?
Hyperpigmentation12015940.140 Why?
Proto-Oncogene Proteins B-raf2201517830.140 Why?
Nephrogenic Fibrosing Dermopathy12013440.130 Why?
Nevus, Pigmented120152830.130 Why?
Ultraviolet Rays1201710580.120 Why?
Rosacea12012470.120 Why?
Clindamycin120121330.120 Why?
Nonprescription Drugs120101130.100 Why?
Gadolinium DTPA120138600.100 Why?
Phototherapy120113250.090 Why?
European Continental Ancestry Group2202071990.080 Why?
Insurance, Health, Reimbursement120104200.080 Why?
African Americans1202049750.070 Why?
Skin Diseases1201210780.070 Why?
Severity of Illness Index32012159550.060 Why?
Molecular Targeted Therapy1201527310.060 Why?
Follow-Up Studies42015388750.060 Why?
Dermatitis, Photoallergic1202040.060 Why?
Dermatitis, Phototoxic12020160.050 Why?
Biopsy, Needle2201717150.050 Why?
Porphyrias12020630.050 Why?
Weight Loss1201122860.050 Why?
Treatment Outcome52015591490.050 Why?
Contrast Media1201352870.050 Why?
Urticaria120201490.050 Why?
Sunlight120203350.050 Why?
Recurrence1201080720.040 Why?
Outpatient Clinics, Hospital120204310.040 Why?
Cost-Benefit Analysis1201052020.040 Why?
Facial Dermatoses120171040.040 Why?
Skin Neoplasms1201552020.040 Why?
Massachusetts1201087170.040 Why?
Genetic Predisposition to Disease12017165040.040 Why?
Patient Acceptance of Health Care1201028610.040 Why?
Lentigo12015510.040 Why?
Melanosis12015780.040 Why?
Proto-Oncogenes120153500.040 Why?
Randomized Controlled Trials as Topic1201090550.030 Why?
Mohs Surgery120151600.030 Why?
Keratoacanthoma12012380.030 Why?
Warts12012690.030 Why?
Middle Aged820172107470.030 Why?
Keratosis, Actinic12012560.030 Why?
Immunohistochemistry22017120570.030 Why?
Oximes120123030.030 Why?
Dermatology120207470.030 Why?
Gels120124540.030 Why?
Pyrimidinones120123220.030 Why?
Adult620172062950.030 Why?
Pilot Projects2201376240.030 Why?
Quality of Life12010101470.030 Why?
Obesity12011113030.020 Why?
Antineoplastic Agents12012135980.020 Why?
Humans1020206607310.020 Why?
Academic Medical Centers1202027130.020 Why?
Female820173651990.020 Why?
Pyridones120125750.020 Why?
Young Adult22017540780.020 Why?
Aged420171569370.020 Why?
Drug Combinations1201218470.020 Why?
Imidazoles1201212630.020 Why?
Male620153439170.020 Why?
Retrospective Studies32020632320.020 Why?
Neoplasms12012184760.020 Why?
Indoles1201218790.020 Why?
Sulfonamides1201217800.020 Why?
Combined Modality Therapy1201590350.020 Why?
Double-Blind Method12012115780.010 Why?
Carcinoma, Squamous Cell1201239110.010 Why?
Case-Control Studies12015212010.010 Why?
Prognosis12017280270.010 Why?
Reproducibility of Results12013189210.010 Why?
Melanoma1201253870.010 Why?
Anti-Bacterial Agents1201266230.010 Why?
Risk Assessment12015229230.010 Why?
United States12020632180.010 Why?
Aged, 80 and over12017576800.010 Why?
Risk Factors12017668870.010 Why?
Mutation12015278320.010 Why?
Magnetic Resonance Imaging12013320950.000 Why?
Alora-Palli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (90)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.